Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
Market news
The True Economic Cost of a US Iran War
America’s Iran War Bill Is Exploding An Iranian strike, likely involving a drone, appears to have damaged a US E-3 Sentry airborne warning and control aircraft at Prince Sultan Air Base in Saudi Arabia. Reports suggest the hit landed near the radar dome attachment point, which matters because the E-3 is not just a surveillance…
March 30, 2026
The ASX's Good Fame and Character Test
AI Stocks Blue Chip Stocks Green Investments Growth Stocks Industrials International Stocks IPOs Tech Stocks Technology
The ASX’s Good Fame and Character Test: The Potential Listing of Oliver Curtis’ $6bn AI Company Firmus Meant A Clarification Was Needed
The ASX's Good Fame and Character Test is not new. But the possible listing of Oliver Curtis' Firmus meant investors are paying more attention than they otherwise would. You see, the Australian Securities Exchange does not let just anyone run a listed company. Before an entity joins its official list, the ASX requires that every director,…
March 30, 2026
Freightways
Industrials International Stocks
Freightways (ASX:FRW): You probably haven’t heard of this $2bn Kiwi company in the ASX 200, but here’s why it could be worth a look
Every time a parcel travels across the Tasman or a courier van pulls up outside an Auckland office, there is a reasonable chance Freightways (ASX:FRW) is behind it. Yet for many retail investors, particularly those in Australia, this company sits in the category of companies they may passively benefit from without ever consciously choosing to…
March 30, 2026
Stocks With Better Fundamentals
Blue Chip Stocks Education
Why Do Stocks With Better Fundamentals Trail Their Peers? And When Should You Accept Waiting for a Re-Rating Is a Lost Cause?
Stocks with better fundamentals trail their peers - that's just the reality of the market. But why? What are the Best ASX Stocks to invest in right now? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] Case in point Last week, it was another day another 4DX Medical (ASX:4DX) re-rating, all because the Mayo Clinic agreed to use its…
March 30, 2026
Lumos Diagnostics
Healthcare Stocks
Lumos Diagnostics (ASX: LDX) Falls Despite FDA Win- Here’s Why the Dip Could Be a Buying Opportunity
Lumos Diagnostics Falls After FDA Waiver Lumos Diagnostics (ASX: LDX) slipped around 3.8% on Friday despite announcing one of the most important milestones in its history. The US Food and Drug Administration granted a CLIA waiver for its flagship FebriDx test, a development that expands the company's addressable US market by 15 times. The dip…
March 30, 2026

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here